HYPD
Hyperion DeFi, Inc. (NASDAQ)
Healthcare — Biotechnology
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Price History
Fundamentals
| Market Cap | $47.60M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-7.55 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 1559.50% |
| ROE | -135.26% |
| Debt/Equity | 1.02 |
| Recommendation | Strong Buy 1.0 |
| Analyst Target | $6.95 |
| Analysts | 2 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 63.1 |
| Beta | 2.48 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $16.35 |
| 52-Week Low | $2.49 |
| 50-Day Avg | $3.54 |
| 200-Day Avg | $4.64 |
| Avg Volume | 590.2K |
| Volume | 491.9K |
Performance Analysis
BULLISHHYPD shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:14 UTC
Back to Screener Export Report